Express News | HC Wainwright & Co. Reiterates Buy on Longboard Pharmaceuticals, Maintains $60 Price Target
Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Longboard Pharmaceuticals (LBPH) and Travere Therapeutics (TVTX)
Express News | Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Buy Rating Affirmed for Longboard Pharmaceuticals Amidst Positive Clinical Progress and Market Potential for Bexicaserin
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
Express News | Wedbush Maintains Outperform on Longboard Pharmaceuticals, Raises Price Target to $34
Longboard Pharmaceuticals (LBPH) Receives a Buy From Wedbush
Express News | Longboard Pharmaceuticals Q1 EPS $(0.42) Beats $(0.52) Estimate
Longboard Pharmaceuticals 1Q Loss/Shr 42c >LBPH
Longboard Pharmaceuticals 1Q Loss/Shr 42c >LBPH
Express News | Longboard Pharmaceuticals Inc: Cash Runway Is Expected to Support Current Planned Operations Into 2027
Express News | Longboard Pharmaceuticals Inc: Ended Q1 2024 With $321.0 Mln in Cash, Cash Equivalents and Investments
Express News | Longboard Pharmaceuticals Q1 Operating Expenses USD 18.11 Million
Express News | Longboard Pharmaceuticals Q1 Net Income USD -14.986 Million
Express News | Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
Express News | Longboard Pharmaceuticals Inc : Baird Initiates Coverage With Outperform Rating; Price Target $36
Buy Rating Affirmed on Longboard Pharmaceuticals With Promising Bexicaserin Developments and Regulatory Milestones Ahead
Institutional Investors in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) See US$68m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them.
Key Insights Institutions' substantial holdings in Longboard Pharmaceuticals implies that they have significant influence over the company's share price 50% of the business is held by the top 8 shar
Express News | HC Wainwright & Co. Reiterates Buy on Longboard Pharmaceuticals, Maintains $60 Price Target
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), Laboratory (LH) and Longboard Pharmaceuticals (LBPH)
Longboard Pharmaceuticals to Reveal Bexicaserin Study Results
No Data